ARVO 2023: Using donor tissue to identify the mechanism cell death of the RPE
April 25th 2023Deborah Ferrington, PhD, spoke with on our on-site team at the 2023 ARVO annual meeting in New Orleans about her presentation on using human donor tissue to identify the mechanism responsible for the death of the retinal pigment epithelium (RPE).
Read More
ARVO 2023: Luxa Biotechnology shares progress of Phase 1/2a clinical trial for AMD treatment
April 25th 2023At ARVO in New Orleans, Luxa Biotechnology shared an update on the progress of a Phase 1/2a clinical trial evaluating transplantation of RPESC-RPE-4W to treat dry age-related macular degeneration (AMD).
Read More
ARVO 2023: Apellis Pharmaceuticals presented Phase 3 data analyses of pegcetacoplan injection for GA
April 24th 2023Apellis Pharmaceuticals Inc. delivered an oral presentation at the ARVO Annual Meeting in New Orleans announcing their post hoc analyses from the Phase 3 OAKS and DERBY studies evaluating pegcetacoplan injection (Syfovre) for the treatment of geographic atrophy (GA).
Read More
ARVO 2023: Nonclinical data by Adverum Biotechnologies regarding potential treatment of wet AMD
April 24th 2023Adverum Biotechnologies Inc. shared nonclinical data at ARVO 2023 in New Orleans that staggered, bilateral administration of Ixo-vec in NHPs was well tolerated with encouraging therapeutic activity and no signals of increased inflammation.
Read More
Apellis launches new GA Won't Wait campaign with actor Henry Winkler
April 17th 2023New GA Won't Wait campaign partners Apellis Pharmaceuticals Inc. with actor Henry Winkler. The goal of this campaign is to raise awareness and educate older adults and their families about geographic atrophy (GA).
Read More
Jennifer Lim shares research on vitrectomy combined with KPro surgery
April 14th 2023Jennifer Lim, MD, FARVO joined David Hutton, Managing Editor, Ophthalmology Times®, to discuss her presentation on keratoprosthesis combined with vitrectomy surgery given at this year's Vit-Buckle Society meeting.
Read More
Gene variants point to a potential cause of age-related macular degeneration
April 8th 2023According to National Eye Institute researchers, the variants generate malformed proteins that alter the stability of the membrane attack complex, which may drive a chronic inflammatory response in the retina.
Read More